[1] Thoma KH, Goldman HM.Central myxoma of the jaw[J]. Oral Surg Oral Med Oral Pathol, 1947, 33(7): B532-540. [2] Halfpenny W, Verey A, Bardsley V.Myxoma of the mandibular condyle: a case report and review of the literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2000, 90(3): 348-353. [3] Sivakumar G, Kavitha B, Saraswathi TR, et al.Odontogenic myxoma of maxilla[J]. Indian J Dent Res, 2008, 19(1): 62-65. [4] Jain VK, Reddy SN.Peripheral odontogenic myxoma of maxillary gingiva: a rare clinical entity[J]. J Indian Soc Periodontol, 2013, 17(5):653-656. [5] Brannon RB.Central odontogenic fibroma, myxoma (odontogenic myxoma, fibromyxoma), and central odontogenic granular cell tumor[J]. Oral Maxillofac Surg Clin North Am, 2004, 16(3):359-374. [6] Jaeger M, Santos J, Domingues M, et al.A novel cell line that retains the morphological characteristics of the cells and matrix of odontogenic myxoma[J]. J Oral Pathol Med, 2000, 29(3):129-138. [7] Martínez-Mata G, Mosqueda-Taylor A, Carlos-Bregni R, et al.Odontogenic myxoma: clinicopathological, immunohistochemical and ultrastructural findings of a multicentric series[J]. Oral Oncol, 2008, 44(6): 601-607. [8] Satelli A, Li S.Vimentin in cancer and its potential as a molecular target for cancer therapy[J]. Cell Mol Life Sci, 2011, 68(18): 3033-3046. [9] Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, et al.Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue[J]. Am J Dermatopathol, 2006, 28(2): 105-111. [10] Skalli O, Ropraz P, Trzeciak A, et al.A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation[J]. J Cell Biol, 1986, 103(6 Pt 2): 2787-2796. [11] Moore BW.A soluble protein characteristic of the nervous system[J]. Biochem Biophys Res Commun, 1965, 19(6): 739-744. |